ONCOLOGY

Surgical management of hepatocellular carcinoma

Sep 13, 2019 by in ONCOLOGY Comments Off on Surgical management of hepatocellular carcinoma

Key points • Patients with cirrhosis are at highest risk of developing hepatocellular carcinoma (HCC) and screening with sonography every 6 months is recommended. • Early-stage HCC should be treated…

read more

Interventional management of hepatocellular carcinoma

Sep 13, 2019 by in ONCOLOGY Comments Off on Interventional management of hepatocellular carcinoma

Key points • Image guided techniques are the most common invasive therapy for unresectable hepatocellular carcinoma (HCC). • Level 1 evidence supports survival benefit chemoembolization. • New embolic devices may…

read more

Cholangiocarcinoma: Diagnosis, management, and prognosis

Sep 13, 2019 by in ONCOLOGY Comments Off on Cholangiocarcinoma: Diagnosis, management, and prognosis

Key points • Although relatively rare, cholangiocarcinoma is the second most common primary hepatobiliary malignancy in the United States, and its incidence is increasing. • Surgical treatment remains the cornerstone…

read more

Principles of radiotherapy

Sep 13, 2019 by in ONCOLOGY Comments Off on Principles of radiotherapy

Key points • The clinical application of radiation oncology balances the dual goals of improved tumor control with reduced treatment-related morbidity. • Over time, technological and biological advances have offered…

read more

Trends in basic science research in interventional radiology: NANOTECHNOLOGY, STEM CELL, RNAi, AND RADIOGENOMICS

Sep 13, 2019 by in ONCOLOGY Comments Off on Trends in basic science research in interventional radiology: NANOTECHNOLOGY, STEM CELL, RNAi, AND RADIOGENOMICS

Introduction Research in interventional radiology has historically been driven by innovation and technological development leading to the conceptualization, investigation, validation, and application of a myriad of novel procedures into clinical…

read more

Systemic therapy in advanced hepatocellular carcinoma

Sep 13, 2019 by in ONCOLOGY Comments Off on Systemic therapy in advanced hepatocellular carcinoma

Key points • Cytotoxic chemotherapy has not proven effective in hepatocellular carcinoma (HCC). Sorafenib is the only approved agent for advanced, unresectable disease. • Current studies are evaluating a wide…

read more
Get Clinical Tree app for offline access